Torsten Goesch
Partner
Torsten Goesch joined Rosetta in 2002. He combines medical training with more than 25 years of operational and deal-making experience in the life science sector. Previously, he held senior operational roles at Biogen and Merck KGa. Torsten holds a MD PhD from the Heinrich Heine University in Dusseldorf and an MBA from the Kellogg School of Management in Chicago.
Torsten has played a key leadership role on the Boards of exited portfolio companies such as Cytochroma, Enobia and STI Technologies. He continues to serve on the Boards of Dilafo and EyeSense.
Meet more of our people